Tyulyandin, S.A., Artamonova, E.V., Zhigulev, A.N., Zhukova, L.G., Koroleva, I.A., et al., Practical recommendations for drug treatment of breast cancer, Zlokach. Opukholi, 2023, vol. 13, pp. 157–200. https://doi.org/10.18027/2224-5057-2023-13-3s2-1-157-200

Article  Google Scholar 

Zhu, J., Min, N., Chen, Y., and Li., X., Neoadjuvant therapy with vs. without anthracyclines for HER2-positive breast cancer: A systematic review and meta-analysis, Ann. Transl. Med., 2023, vol. 11, no. 5, p. 200. https://doi.org/10.21037/atm-22-4030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding, Y., Ding, K., He, X., Mo, W., and Liang, C., The value of neoadjuvant anthracycline-based regimens for her2-positive breast cancer: A systematic review and meta-analysis including 1366 patients, Clin. Med. Insights: Oncol., 2023, vol. 17, pp. 1–12. https://doi.org/10.1177/11795549231195293

Article  Google Scholar 

Spring, L.M., Fell, G., Arfe, A., Sharma, C., Greenup, R., et al., Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive meta-analysis, Clin. Cancer Res., 2020, vol. 26, pp. 2838–2848. https://doi.org/10.1158/1078-0432.CCR-19-3492

Article  PubMed  PubMed Central  Google Scholar 

Kim, H.S., Yoo, T.K., Park, W.C., and Chae, B.J., Potential benefits of neoadjuvant chemotherapy in clinically node-positive luminal subtype breast cancer, J. Breast Cancer, 2019, vol. 22, pp. 412–424. https://doi.org/10.4048/jbc.2019.22.e35

Article  PubMed  PubMed Central  Google Scholar 

Barbieri, E., Gentile, D., Bottini, A., Sagona, A., Gatzemeier, W., et al., Neo-adjuvant chemotherapy in luminal, node positive breast cancer: characteristics, treatment and oncological outcomes: A single center’s experience, Eur. J. Breast Health, 2021, vol. 17, pp. 356–362. https://doi.org/10.4274/ejbh.galenos.2021.2021-4-8

Article  PubMed  PubMed Central  Google Scholar 

Kang, Y.J., Han, W., Park, S., You, J.Y., Yi, H.W., et al., Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy, Breast Cancer Res. Treat., 2017, vol. 166, pp. 473–480. https://doi.org/10.1007/s10549-017-4423-1

Article  PubMed  Google Scholar 

Vuger, A.T., Tiscoski, K., Apolinario, T., and Cardoso, F., Anthracyclines in the treatment of early breast cancer friend or foe?, Breast, 2022, vol. 65, pp. 67–76. https://doi.org/10.1016/j.breast.2022.06.007

Article  PubMed  PubMed Central  Google Scholar 

van der Voort, A., van Ramshorst, M.S., van Werkhoven, E.D., Mandjes, I.A., Kemper, I., et al., Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual ERBB2 blockade in patients with ERBB2-positive breast cancer: A secondary analysis of the TRAIN-2 randomized, phase 3 trial, JAMA Oncol., 2021, vol. 7, pp. 978–984. https://doi.org/10.1001/jamaoncol.2021.1371

Article  PubMed  Google Scholar 

Nanda, R., Liu, M.C., Yau, C., Shatsky, R., Pusztai, L., et al., Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-stage breast cancer: An analysis of the ongoing phase 2 adaptively randomized I-SPY2 trial, JAMA Oncol., 2020, vol. 6, pp. 676–684. https://doi.org/10.1001/jamaoncol.2019.6650

Article  PubMed  Google Scholar 

Mukai, H., Uemura, Y., Akabane, H., Watanabe, T., Park, Y., et al., Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer, Br. J. Cancer, 2021, vol. 125, pp. 1217–1225. https://doi.org/10.1038/s41416-021-01531-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allison, K.H., Hammond, M.E.H., Dowsett, M., McKernin, S.E., Carey, L.A., et al., Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update, J. Clin. Oncol., 2020, vol. 38, no. 12, pp. 1346–1366. https://doi.org/10.1200/JCO.19.02309

Article  PubMed  Google Scholar 

Wolff, A.C., Hammond, M.E.H., Allison, K.H., Harvey, B.E., Mangu, P.B., et al., Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update, Arch. Pathol. Lab. Med., 2018, vol. 142, no. 11, pp. 1364–1382. https://doi.org/10.5858/arpa.2018-0902-SA

Article  PubMed  Google Scholar 

Ibragimova, M.K., Kravtsova, E.A., Tsyganov, M.M., and Litviakov, N.V., CNA landscape of HER2-negative breast cancer in anthracycline-based neoadjuvant chemotherapy regimens, Acta Nat., 2023, vol. 15, pp. 67–74. https://doi.org/10.32607/actanaturae.20377

Article  Google Scholar 

López, C., Barnon, M.T., Beacon, T.H., Nardocci, G., and Davie, J.R., The key role of differential broad H3K4me3 and H3K4ac domains in breast cancer, Gene, 2022, vol. 826, p. 5. https://doi.org/10.1016/j.gene.2022.146463

Article  CAS  Google Scholar 

Bosco, E.E., Christie, R.J., Carrasco, R., Sabol, D., Zha, J., et al., Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer, Oncotarget, 2018, vol. 9, pp. 22960–22975. https://doi.org/10.18632/oncotarget.25160

Article  PubMed  PubMed Central  Google Scholar 

Hall, B.L., Leronni, D., Miyagawa, Y., Goins, W.F., Glorioso, J.C., et al., Generation of an oncolytic herpes simplex viral vector completely retargeted to the GDNF receptor GFRα1 for specific infection of breast cancer cells, Int. J. Mol. Sci., 2020, vol. 21, no. 22, p. 8815. https://doi.org/10.3390/ijms21228815

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong, P.-J., Shao, Y.-C., Huang, S.-R., Zeng, Y.-F., Yuan, X.-N., et al., Hypoxia-associated prognostic markers and competing endogenous RNA co-expression networks in breast cancer, Front. Oncol., 2020, vol. 10, p. 579868. https://doi.org/10.3389/fonc.2020.579868

Article  PubMed  PubMed Central  Google Scholar 

Huang, D., Chen, X., Zeng, X., Lao, L., Li, J., et al., Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer, Nat. Immunol., 2021, vol. 22, pp. 865–879. https://doi.org/10.1038/s41590-021-00939-9

Article  CAS  PubMed  Google Scholar 

Chen, X., Zhang, J., Lei, X., Yang, L., Li, W., et al., CD1C is associated with breast cancer prognosis and immune infiltrates, BMC Cancer, 2023, vol. 23, p. 129. https://doi.org/10.1186/s12885-023-10558-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui, Y., Fan, Y., Zhao, G., Zhang, Q., Bao, Y., et al., Novel lncRNA PSMG3-AS1 functions as a miR-143-3p sponge to increase the proliferation and migration of breast cancer cells, Oncol. Rep., 2020, vol. 43, no. 1, pp. 229–239. https://doi.org/10.3892/or.2019.7390

Article  CAS  PubMed  Google Scholar 

Lu, C., Qiao, P., Sun, Y., Ren, C., and Yu, Z., Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer, Clin. Transl. Med., 2021, vol. 11, p. e400. https://doi.org/10.1002/ctm2.400

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faughnan, P., Mohi, G., and Singh, C., The roles of PIM1 and PIM2 kinases in the progression and metastasis of triple negative breast cancer, Cancer Res., 2022, vol. 82, p. 149. https://doi.org/10.1158/1538-7445.AM2022-149

Article  Google Scholar 

Xin, Z.C., Hu, H.W., Lao, Z.H., Zhu, L.Q., Biskup, E., et al., p-CREB-1 at Ser 133 is a potential marker for breast cancer, Eur. Rev. Med. Pharmacol. Sci., 2020, vol. 24, pp. 11628–11638.

PubMed  Google Scholar 

Espinosa, M., Lizarraga, F., Vazquez-Santillan, K., Hidalgo-Miranda, A., Pina-Sanchez, P., et al., Coexpression of Smac/DIABLO and estrogen receptor in breast cancer, Cancer Biomarkers, 2021, vol. 30, no. 4, pp. 429–446. https://doi.org/10.3233/CBM-200535

Article  CAS  PubMed  Google Scholar 

Cui, R., Chen, P., Wang, Y., Lu, R., Ji, M., et al., Cohesin RAD21 gene promoter methylation correlated with better prognosis in breast cancer patients, Cytogenet. Genome Res., 2022, vol. 162, no. 3, pp. 109–118. https://doi.org/10.1159/000524735

Article  CAS  PubMed  Google Scholar 

Sun, N., Gao, P., Li, Y., Yan, Z., Peng, Z., et al., Screening and identification of key common and specific genes and their prognostic roles in different molecular subtypes of breast cancer, Front. Mol. Biosci., 2021, vol. 8, p. 619110. https://doi.org/10.3389/fmolb.2021.619110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kähkönen, T.E., Halleen, J.M., and Bernoulli, J., Identification of genetic signatures in bone metastasis of breast and prostate cancer, Cancer Res., 2022, vol. 82, p. 5740. https://doi.org/10.1158/1538-7445.AM2022-5740

Article  Google Scholar